학술논문

A weight-loss Mediterranean diet/lifestyle intervention ameliorates inflammation and oxidative stress in patients with obstructive sleep apnea: results of the "MIMOSA" randomized clinical trial.
Document Type
Article
Source
European Journal of Nutrition. Oct2021, Vol. 60 Issue 7, p3799-3810. 12p. 1 Diagram, 2 Charts.
Subject
*MEDITERRANEAN diet
*LIFESTYLES
*EVALUATION of human services programs
*CONTINUOUS positive airway pressure
*INFLAMMATION
*RANDOMIZED controlled trials
*OXIDATIVE stress
*SLEEP apnea syndromes
*WEIGHT loss
*DESCRIPTIVE statistics
*RESEARCH funding
*STATISTICAL sampling
Language
ISSN
1436-6207
Abstract
Purpose: Inflammation and oxidative stress are implicated in obstructive sleep apnea (OSA) pathophysiology. We aimed at exploring whether the combination of a weight-loss Mediterranean diet/lifestyle intervention with OSA standard care, i.e., continuous positive airway pressure (CPAP) prescription, can lead to greater improvements in inflammation and oxidative stress, compared to standard care alone. Methods: This was a randomized controlled clinical trial in 187 adult, overweight patients with moderate-to-severe OSA. Participants were randomized to a standard care (SCG, n = 65), a Mediterranean diet (MDG, n = 62) or a Mediterranean lifestyle group (MLG, n = 60). All groups received OSA standard care. Intervention arms participated in a 6-month behavioral weight-loss intervention based on the Mediterranean diet, while the MLG also received counselling on physical activity and sleep habits. Results: Seven patients were excluded and 53/180 were lost to follow-up. In intention to treat analysis (n = 180), the SCG did not exhibit changes in any of the markers assessed. Post-intervention age-, sex-, baseline- and CPAP use-adjusted plasma high sensitivity C-reactive protein levels (mg/L) were lower in the MDG and the MLG compared to the SCG (mean difference − 1.33, P = 0.039 and − 1.68, P = 0.007, respectively). The MLG also exhibited lower urinary 8-iso prostaglandin F2a levels (ng/mg creatinine) compared to the SCG and the MDG (mean difference − 1.10, P < 0.0001 and − 0.80, P = 0.001, respectively). Adiponectin and oxidized guanine levels were not altered in any of the study groups. Results were similar in per protocol analysis (n = 127). Conclusion: A weight-loss Mediterranean diet/lifestyle intervention on top of CPAP has anti-inflammatory and antioxidant benefits in OSA. Registration: The trial was prospectively registered at ClinicalTrials.gov (NCT02515357) on August 4, 2015. [ABSTRACT FROM AUTHOR]